Ocuphire Pharma shares latest in ophthalmic pipeline

June 19, 2022

1 min watch

Source:

Healio Interviews


Disclosures:
Pepose reports being chief medical advisor of Ocuphire Pharma.


We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Jay S. Pepose, MD, PhD, shares an update on some of the ophthalmic agents that Ocuphire Pharma has in the pipeline.

Jay S. Pepose, MD, PhD; David W. Mullin

Source link

© Mongobook 2022 | Designed by PixaHive.